Quick Search:

uzh logo
Browse by:

Zurich Open Repository and Archive

Maintenance: Tuesday, July the 26th 2016, 07:00-10:00

ZORA's new graphical user interface will be relaunched (For further infos watch out slideshow ZORA: Neues Look & Feel). There will be short interrupts on ZORA Service between 07:00am and 10:00 am. Please be patient.

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-24287

Kretschmar, O; Sglimbea, A; Daehnert, I; Riede, F T; Weiss, M; Knirsch, W (2010). Interventional closure of atrial septal defects with the Solysafe Septal Occluder - Preliminary results in children. International Journal of Cardiology, 143(3):373-377.

[img] PDF (Verlags-PDF) - Registered users only
View at publisher


BACKGROUND: To report usability, safety, and efficacy of the self-centering Solysafe Septal Occluder for transcatheter closure of secundum type atrial septal defect (ASD) in paediatric patients. METHODS: Retrospective observational clinical study in two tertiary care centers for congenital heart diseases. Patients: First 37 (median age 8.7 years, 68% female) consecutive patients with an ASD stretched diameter up to 22 mm in whom a Solysafe Septal Occluder was used to close a haemodynamically significant ASD. Interventions: Transcatheter closure of ASD was performed under general anaesthesia with trans-esophageal echo guidance. Stretched diameter of the ASD was assessed by balloon sizing. Main outcome measures: Rate of success, complete closure rate, and complications (defined as vascular complications, device-related complications such as embolism, thrombus formation, device erosions, infections, and arrhythmia) during follow up. RESULTS: 37 procedures were performed, success rate was 87% (32 of 37 pts.). A missing retroaortic rim was the main reason for device failure. Complete ASD closure rate was 78% immediately in cath lab (25 of 32 pts.), 90% after four weeks (28 of 31 pts.), 94% after three months (29 of 31 pts.), and 100% after six months (20 of 20 pts.). Procedure-related complication was femoral vein thrombosis in one patient. CONCLUSIONS: The Solysafe Septal Occluder is a feasible, safe, and clinically efficient new device for interventional closure of small to medium sized ASDs less than 23 mm stretched diameter in childhood. Limitations for the Solysafe device are ASDs with absent retroaortic rims and very small children with a body weight <10 kg.


7 citations in Web of Science®
7 citations in Scopus®
Google Scholar™



0 downloads since deposited on 19 Feb 2010
0 downloads since 12 months

Additional indexing

Contributors:Int J Cardiol. 2010 Sep 3;143(3):373-7. Epub 2009 Apr 14.
Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Children's Hospital Zurich > Medical Clinic
04 Faculty of Medicine > University Children's Hospital Zurich > Clinic for Surgery
Dewey Decimal Classification:610 Medicine & health
Deposited On:19 Feb 2010 00:39
Last Modified:05 Apr 2016 13:34
Publisher DOI:10.1016/j.ijcard.2009.03.086
PubMed ID:19368981

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page